10X Genomics
Jeremy Lackey currently serves as VP of Chemistry at 10x Genomics and is also an Advisory Board Member at Axiome. Previously, Lackey was VP and Senior Director of Chemistry at Twist Bioscience, where contributions included advanced product development in genomics and drug discovery, as well as inventing a novel method for template-free enzymatic DNA synthesis. As a co-founder of Quantum-Si, Lackey established a multidisciplinary core team, led the chemistry efforts, and innovated next-generation protein sequencing methods. Additional experience includes roles at Agilent Technologies and Alnylam Pharmaceuticals, focusing on DNA microarray synthesis, oligonucleotide technologies, and drug discovery. Lackey holds a PhD in Chemistry from McGill University and a Bachelor of Science in Biopharmaceutical Science from the University of Ottawa.
This person is not in any teams
10X Genomics
18 followers
10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company's integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2020 based on publications and all of the top 20 global pharmaceutical companies by 2020 research and development spend, and have been cited in over 3,000 research papers on discoveries ranging from oncology to immunology and neuroscience. The company's patent portfolio comprises more than 1,200 issued patents and patent applications.